Cargando…

Amyloid Beta Annular Protofibrils in Cell Processes and Synapses Accumulate with Aging and Alzheimer-Associated Genetic Modification

Amyloid β (Aβ) annular protofibrils (APFs) have been described where the structure is related to that of β barrel pore-forming bacterial toxins and exhibits cellular toxicity. To investigate the relationship of Aβ APFs to disease and their ultrastructural localization in brain tissue, we conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kokubo, Hideko, Kayed, Rakez, Glabe, Charles G., Staufenbiel, Matthias, Saido, Takaomi C., Iwata, Nobuhisa, Yamaguchi, Haruyasu
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925098/ https://www.ncbi.nlm.nih.gov/pubmed/20798763 http://dx.doi.org/10.4061/2009/689285

Ejemplares similares

Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils
por: Pires, Ricardo H., et al.
Publicado: (2012)

A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer’s disease
por: Chen, Zu-Lin, et al.
Publicado: (2023)

Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin
por: Shin, Thuzar M, et al.
Publicado: (2008)

Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure
por: Sokolov, Yuri, et al.
Publicado: (2006)

Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic
por: Dubnovitsky, Anatoly, et al.
Publicado: (2013)

Quantification and targeting of elusive neurotoxic amyloid oligomers
por: Bhatt, Nemil, et al.
Publicado: (2022)

Correction: Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic
por: Dubnovitsky, Anatoly, et al.
Publicado: (2013)

Amyloid Oligomers and Protofibrils, but Not Filaments, Self-Replicate from Native Lysozyme
por: Mulaj, Mentor, et al.
Publicado: (2014)

Formation of amyloid loops in brain tissues is controlled by the flexibility of protofibril chains
por: Miller, Alyssa, et al.
Publicado: (2023)

Atomic resolution dynamics on the surface of amyloid β protofibrils probed by solution NMR
por: Fawzi, Nicolas L., et al.
Publicado: (2011)

Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils
por: Groenning, Minna, et al.
Publicado: (2015)

Protofibril–Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation
por: Hasecke, Filip, et al.
Publicado: (2020)

Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversity
por: Bhopatkar, Anukool A., et al.
Publicado: (2023)

High-molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain
por: Upadhaya, Ajeet Rijal, et al.
Publicado: (2012)

An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
por: Kizuka, Yasuhiko, et al.
Publicado: (2015)

Conformation‐specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
por: Bonito‐Oliva, Alessandra, et al.
Publicado: (2019)

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
por: Sengupta, Urmi, et al.
Publicado: (2016)

Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
por: SAIDO, Takaomi C.
Publicado: (2013)

Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2020)

Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010)

Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
por: Iwata, Nobuhisa, et al.
Publicado: (2013)

Annular PIP(3) accumulation controls actin architecture and modulates cytotoxicity at the immunological synapse
por: Le Floc’h, Audrey, et al.
Publicado: (2013)

Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice
por: Martins, Ivo Cristiano, et al.
Publicado: (2008)

Correction: Annular PIP(3) accumulation controls actin architecture and modulates cytotoxicity at the immunological synapse
por: Le Floc’h, Audrey, et al.
Publicado: (2017)

por: Sokolov, Yuri, et al.
Publicado: (2006)

ApoE4-Driven Accumulation of Intraneuronal Oligomerized Aβ42 following Activation of the Amyloid Cascade In Vivo Is Mediated by a Gain of Function
por: Zepa, Lia, et al.
Publicado: (2011)

Partial Destabilization of Amyloid-β Protofibril by Methionine Photo-Oxidation: A Molecular Dynamic Simulation Study
por: Maghsoodi, Fahimeh, et al.
Publicado: (2023)

Immunotherapy for the treatment of Alzheimer’s disease: amyloid-β or tau, which is the right target?
por: Castillo-Carranza, Diana L, et al.
Publicado: (2013)

Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
por: Fernandez‐Perez, Eduardo J., et al.
Publicado: (2021)

Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice
por: Rasool, Suhail, et al.
Publicado: (2012)

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
por: Marcatti, Michela, et al.
Publicado: (2022)

Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures
por: Nikitidou, Elisabeth, et al.
Publicado: (2017)

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes
por: Bortoletto, Angelina S., et al.
Publicado: (2022)

Accumulation of amyloid beta in human glioblastomas
por: Zayas‐Santiago, A., et al.
Publicado: (2020)

Astrocytes deficient in circadian clock gene Bmal1 show enhanced activation responses to amyloid-beta pathology without changing plaque burden
por: McKee, Celia A., et al.
Publicado: (2022)

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
por: Lannfelt, Lars, et al.
Publicado: (2014)

Mechanisms of U87 Astrocytoma Cell Uptake and Trafficking of Monomeric versus Protofibril Alzheimer’s Disease Amyloid-β Proteins
por: Li, Yali, et al.
Publicado: (2014)

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
por: Kayed, Rakez, et al.
Publicado: (2007)

Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continues
por: Kayed, Rakez
Publicado: (2021)

Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses
por: Romani, Armando, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_po8dr43h8rifsabtr355em0noj